Oh the news is very good, but we have to keep in mind that it was one patient that they were left with no other choice but to complete this experimental treatment. If they receive FDA approval for trials and once they get up to date with SEC reporting sometime in this third quarter, then justification can be made for a higher market cap.
Market Data 
Markets 
AI
